HCPLive Network

Study Shows Smoking Cuts Life Expectancy by More Than a Decade

WEDNESDAY, Jan. 23 (HealthDay News) -- Smokers typically die at least a decade earlier than nonsmokers, but this can be at least partially reversed by quitting smoking, according to a study published in the Jan. 24 issue of the New England Journal of Medicine.

Prabhat Jha, M.D., from the Center for Global Health Research in Toronto, and colleagues reviewed the smoking and smoking-cessation histories of 202,248 adults, aged 25 years and older (113,752 women and 88,496 men) who were interviewed between 1997 and 2004, and their association with the causes of death by the end of 2006 (8,236 deaths in women and 7,479 in men).

The researchers found that, for those aged 25 to 79 years, current smokers had a higher rate of death from any cause than never smokers (hazard ratio, 3.0 for women and 2.8 for men). This excess mortality was largely due to diseases that could be caused by smoking, including neoplastic, vascular, and respiratory diseases. For those who had never smoked, the likelihood of surviving from 25 to 79 years of age was about twice as high as for current smokers (70 versus 38 percent for women and 61 versus 26 percent for men). The life expectancy of current smokers was more than 10 years shorter than that of never smokers, and those who quit smoking between 25 to 54 years of age gained about six to 10 years of life.

"Smokers lose at least one decade of life expectancy, as compared with those who have never smoked," Jha and colleagues conclude. "Cessation before the age of 40 years reduces the risk of death associated with continued smoking by about 90 percent."

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Smoking cessation is associated with improved survival for patients who undergo percutaneous coronary intervention, according to a study published in the Nov. 1 issue of The Journal of Cardiology.
Landmark study results presented at ACC.13 reveal patients with vascular disease treated with niacin therapy face increased risk of myopathy and other adverse events.
In addition to traditional cardiovascular disease risk factors, in patients with type 2 diabetes, coronary artery calcium predicts the risk of cardiovascular death, according to a study published online Dec. 10 in Diabetes Care.
For former light smokers who quit ≤15 years ago, the risks of incident heart failure or cardiovascular mortality are not significantly increased, according to a study presented at the American Heart Association's 2013 Scientific Sessions, held from Nov. 16 to 19 in Dallas, TX.
In men, supplemental calcium intake is associated with an increased risk of death from cardiovascular disease, according to a study published online Feb. 4 in JAMA Internal Medicine.
Patterns of higher blood pressure levels in young adulthood are associated with increased risk of coronary artery calcification in middle age, according to research published in the Feb. 5 issue of the Journal of the American Medical Association.
Although oral antiplatelet therapy is broadly supported as preventive therapy for patients with established atherosclerotic vascular disease, researchers say emerging evidence for specific agents shows heterogeneous outcomes by symptomatic vascular bed, and patterns of use may vary by symptomatic territory.
More Reading